Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation

Neuropharmacology. 2020 Sep 1:174:108071. doi: 10.1016/j.neuropharm.2020.108071. Epub 2020 Apr 13.

Authors

Kristin R Anderson¹, Katie M Hoffman², Julie M Miwa³

Affiliations

¹ Department of Biological Sciences, Lehigh University, USA.
² Department of Biological Sciences, Lehigh University, USA. Electronic address: [email protected].
³ Department of Biological Sciences, Lehigh University, USA. Electronic address: [email protected].

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review

MeSH terms

Adaptor Proteins, Signal Transducing / chemistry
Adaptor Proteins, Signal Transducing / metabolism
Adaptor Proteins, Signal Transducing / therapeutic use*
Animals
Anxiety / drug therapy*
Anxiety / metabolism
Anxiety / psychology
Cholinergic Agents / chemistry
Cholinergic Agents / metabolism
Cholinergic Agents / therapeutic use*
Cholinergic Neurons / drug effects
Cholinergic Neurons / metabolism*
Cognition / drug effects*
Cognition / physiology
Humans
Nicotinic Agonists / chemistry
Nicotinic Agonists / metabolism
Nicotinic Agonists / therapeutic use
Nicotinic Antagonists / chemistry
Nicotinic Antagonists / metabolism
Nicotinic Antagonists / therapeutic use
Protein Structure, Secondary
Receptors, Nicotinic / chemistry
Receptors, Nicotinic / metabolism*

Substances

Adaptor Proteins, Signal Transducing
Cholinergic Agents
LYNX1 protein, human
Nicotinic Agonists
Nicotinic Antagonists
Receptors, Nicotinic

Grants and funding